Welcome to our dedicated page for PMGC Holdings SEC filings (Ticker: ELAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PMGC Holdings Inc. filings document material events, subsidiary announcements, capital-structure disclosures, material agreements, governance matters, and Nasdaq-listed common stock information. Recent Form 8-K reports include Regulation FD disclosures and press-release exhibits related to NorthStrive Biosciences, NorthStrive Defense Tech, AGA Precision Systems, SVM Machining, Pacific Sun Packaging, and corporate financing activity.
The company’s regulatory record identifies PMGC as a Nevada corporation with common stock listed on The Nasdaq Stock Market under the symbol ELAB and as an emerging growth company. Filing categories also cover shareholder voting matters, operating and financial results, security-structure information, and subsidiary-level developments involving manufacturing agreements, intellectual property, packaging markets, and defense technology initiatives.
PMGC Holdings Inc., which trades on Nasdaq under the symbol ELAB, reported results from its 2026 Annual Meeting and a key change to its corporate governance. Shareholders approved amended bylaws that classify the Board of Directors into two staggered classes, Class I and Class II, with different term lengths.
The staggered structure will start after the 2027 Annual Meeting. Initial Class I directors will serve until the 2030 Annual Meeting, and initial Class II directors will serve until the 2028 meeting. At the 2026 Annual Meeting, all five director nominees were elected with about 99.8% of votes cast, and shareholders also approved the staggered board proposal and ratified HTL International, LLC as auditor for the 2026 fiscal year. A quorum was present, with 6,564,834 shares represented, or 60.13% of 10,916,625 outstanding shares entitled to vote.
PMGC Holdings Inc., through its subsidiary NorthStrive Defense Tech LLC, entered into a binding term sheet with the Florida State University Research Foundation to obtain an exclusive, worldwide, sublicensable license to patent rights related to U.S. Patent No. 12,291,334 for aerospace and defense technologies. The license includes tiered earned royalties on net sales by product category and cumulative net sales, an annual minimum royalty, a sublicensing revenue share, and an annual maintenance fee, while PMGC follows a multi-year development plan that can be adjusted by mutual agreement.
NorthStrive Defense Tech also signed an Educational Research Agreement with the Florida State University Research Foundation under which it will fund $490,657 of research by the Center for Intelligent Systems, Control, and Robotics over a 12‑month term starting June 1, 2026. Any inventions made during the research will belong to the foundation, with NorthStrive Defense Tech receiving an option to negotiate a royalty-bearing license and a royalty‑free, non‑exclusive internal use license, and either party may terminate the research agreement with 30 days’ written notice.
PMGC Holdings Inc. reported that options to acquire 450,277 shares of its common stock were granted to GB Capital Ltd., an entity wholly owned by Chief Executive Officer Graydon Bensler. The non-statutory stock options have an exercise price of $1.77 per share, are 100% vested, and immediately exercisable as of June 1, 2026.
The grant was issued as partial consideration for consultant services provided to the company through GB Capital Ltd. Following this award, GB Capital Ltd. indirectly holds options covering a total of 450,279 shares of PMGC Holdings Inc. common stock.
Braeden Lichti and Northstrive Companies Inc. amend their ownership disclosure for PMGC Holdings Inc. They report beneficial ownership of 450,313 shares of Common Stock, representing 7.40% of the class, based on 5,631,282 shares outstanding on June 1, 2026.
The stake includes 32 shares of Common Stock held by Northstrive, 2 shares underlying options previously granted to Mr. Lichti and held by Northstrive, 2 shares underlying warrants held by BWL Investments Ltd., and 450,277 shares underlying options granted to Northstrive on June 1, 2026 as partial consideration for consulting services under the issuer’s 2025 Equity Incentive Plan.
The amendment also reflects that prior holdings were reassigned from other entities to Northstrive and adjusted for multiple reverse stock splits. Both reporting persons disclose zero sole voting or dispositive power and shared power over the reported shares.
PMGC Holdings Inc. received a Schedule 13D from Graydon Bensler and his wholly owned entity GB Capital Ltd. reporting beneficial ownership of 450,287 shares of Common Stock, representing 7.40% of the class. This total includes shares underlying options granted to GB Capital Ltd. on June 1, 2026 as partial consideration for consulting services under the company’s 2025 Equity Incentive Plan. The percentage is based on 5,631,282 shares of Common Stock issued and outstanding as of June 1, 2026. Voting and dispositive power over these shares is shared between Mr. Bensler and GB Capital Ltd.
PMGC Holdings Inc. director Jeffrey Parry received a grant of stock options as part of his compensation. On June 1, 2026, he was awarded options to acquire 75,046 shares of common stock at an exercise price of $1.77 per share.
The options were granted under the company’s 2025 Equity Incentive Plan, as amended. They are non-statutory stock options that are 100% vested and immediately exercisable as of the grant date and expire on June 1, 2031. Following this grant, Parry holds 75,046 options directly.
PMGC Holdings Inc. reported that independent director Georgiy Kovalyov received a grant of stock options as compensation for his board service. The award covers 75,046 options for common stock at an exercise price of $1.77 per share, expiring on June 1, 2031.
The options were granted under the company’s 2025 Equity Incentive Plan. They are described as non-statutory stock options that are 100% vested and immediately exercisable as of the grant date, giving Kovalyov the right to acquire an equal number of common shares.
PMGC Holdings Inc. reported that director Juliana Daley received a grant of 75,046 non-statutory stock options to purchase Common Stock at an exercise price of $1.77 per share. The options were granted under the 2025 Equity Incentive Plan as partial consideration for her services as an independent director.
The options are 100% vested and immediately exercisable as of the June 1, 2026 grant date and expire on June 1, 2031. Following this grant, Daley holds 75,046 options directly.
PMGC Holdings Inc. director Braeden Lichti reported an indirect award of stock options through Northstrive Companies Inc. On June 1, 2026, Northstrive received 450,277 options to acquire Common Stock at an exercise price of $1.77 per share, expiring on June 1, 2031.
The options were granted under the Company’s 2025 Equity Incentive Plan as partial consideration for services provided through Northstrive. They are described as non-statutory stock options that are 100% vested and immediately exercisable on the grant date. Following this grant, entities associated with Lichti hold instruments convertible into a total of 450,281 shares of Common Stock.
PMGC Holdings Inc. reported a 9.99% beneficial ownership position held by Streeterville Capital LLC. The filing states Streeterville beneficially owns 453,920 shares of Common Stock, representing 9.99% of the 4,543,751 shares outstanding as of May 14, 2026 (per the Issuer's 10-Q). The ownership level reflects a contractual ownership cap of 9.99% under Securities Purchase Agreements (including prepaid purchase arrangements) dated September 23, 2025 and April 16, 2026.
The report is filed by Streeterville Capital LLC, Streeterville Management LLC (manager), and John M. Fife (sole member of the manager) and states sole voting and dispositive power over the 453,920 shares.